Cargando…
Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations
Large granular lymphocyte (LGL) leukemia is a rare hematological disorder with expansion of the T‐cell or natural killer (NK) cell lineage. Signal transducer and activator of transcription 3 (STAT3) exhibits somatic activating mutations in 30%‐40% of LGL leukemia cases. Transcriptional targets of ST...
Autores principales: | Olson, Kristine C., Moosic, Katharine B., Jones, Marieke K., Larkin, Paige M. K., Olson, Thomas L., Toro, Mariella F., Fox, Todd E., Feith, David J., Loughran, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520360/ https://www.ncbi.nlm.nih.gov/pubmed/32710512 http://dx.doi.org/10.1002/cam4.3246 |
Ejemplares similares
-
Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia
por: Kulling, Paige M., et al.
Publicado: (2018) -
Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis
por: Moosic, Katharine B., et al.
Publicado: (2022) -
Emergence of a STAT3 mutated NK clone in LGL leukemia
por: Yan, Yiyi, et al.
Publicado: (2014) -
Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia
por: Savola, Paula, et al.
Publicado: (2018) -
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
por: Andersson, E I, et al.
Publicado: (2013)